KDM4C and osteosarcoma: These findings are consistent with the previous observation that the expression of KDM4C reduces H3K9me3 levels in the ATF4 promoter, favoring its expression and transactivation to reprogram amino acid metabolism and cell proliferation in neuroblastoma and osteosarcoma cells [49].